ResMed has had the market on sleep apnea cornered for a while, but new weight-loss drugs might be creeping in. We look at what could change based on recent studies and some other businesses that have established lifelong customers.
(00:21) Bill Barker and Dylan Lewis discuss:
- How weight-loss drugs like Eli Lilly’s Zepbound might be coming for ResMed and ... Show More
Jun 2025
The business of not dying
Is longevity the next growth industry? We look at why billionaires are betting on 'rejuvenation' tech and whether any of this could help more of us live beyond 100. We meet the entrepreneurs selling 'superfoods', personalised health plans, and longevity consulting, hoping to cash ... Show More
17m 28s
Jun 2024
Reach Customers, Spend Less With These Expert Tips
<p>The marketing landscape is ever changing. Digital advertising costs are rising and there are more restrictions to access customer data. How can businesses navigate these realities and reach their business goals? </p><p>Eric Seufert, founder and partner at Heracles Capital, and ... Show More
26m 15s
Jun 2024
The weight-loss drug revolution
Diabetes and obesity drugs like Ozempic, Wegovy and Mounjaro have become famous for helping users shed big amounts of weight. It's a market that could soon be worth more than $100 billion. Two companies dominate this space, Novo Nordisk which makes Ozempic and Eli Lilly, maker of ... Show More
17m 28s
Jun 2023
Long-Lasting Companies, Pandemic Monitoring & Deepfake Businesses
Episode 469: Sam Parr (@TheSamParr) and Shaan Puri (@ShaanVP) talk about companies that have lasted more than 100 years, business opportunities using deepfake technology, knowing your values, and one listener's question is answered.
Want to see more MFM? Subscribe to the MFM YouT ... Show More
1h 2m